Kyntra Bio, Inc. (KYNB)
5.21
-0.07
(-1.33%)
USD |
NASDAQ |
Oct 21, 16:00
5.205
0.00 (0.00%)
After-Hours: 20:00
Kyntra Bio Net Income (Annual) : -58.20M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -58.20M |
| December 31, 2024 | -153.10M |
| December 31, 2023 | -322.97M |
| December 31, 2022 | -293.65M |
| December 31, 2021 | -290.02M |
| December 31, 2020 | -189.29M |
| December 31, 2019 | -76.97M |
| Date | Value |
|---|---|
| December 31, 2018 | -86.42M |
| December 31, 2017 | -120.88M |
| December 31, 2016 | -61.68M |
| December 31, 2015 | -85.78M |
| December 31, 2014 | -59.50M |
| December 31, 2013 | -14.94M |
| December 31, 2012 | -32.57M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Vericel Corp. | 16.52M |
| Nektar Therapeutics | -164.08M |
| Capricor Therapeutics, Inc. | -105.04M |
| ARS Pharmaceuticals, Inc. | -171.30M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |